February 22 download agenda
Session & Discussion: Biosimilars 10 years +

Moderator: Rodeina Challand, VP Scientific Affairs, BioFactura 09:30 Biosimilars 10 years +
09:30-09:50 Pure Play Global Biosimilar Strategy – Anil Okay, General Manager, Adalvo, Chief Commercial Officer, Alvotech
09:50-10:10 Bidding on the cost competitiveness and biosimilar capabilities: what innovative approaches could help to drive commercial sustainability at a global scale? – Gopal Rao, General Manager, Global BD & Licensing, Lupin
10:10-10:20 Q&A

Discussion: Partnerships & Investment in the Biosimilar Space

With a cumulative number of biosimilar development programs, multiple molecules and competing products in the market – what are the tactical considerations for sponsors and developers?
Sangeeta Gupta Nair, Head BD & Licensing Biosimilars (International Region), Sandoz
Xiaoli Hu, Head of Business Development, Xbrane
Eduardo Cioppi, Global Market Access & Public Affairs Director, mAbxience

Coffee Break
Biosimilars: Global Markets Development

11:00–11:15 Challenges and opportunities in China Pharmaceutical market – Huiguo Hu, Chief Commercial Officer & Senior Vice President & Board Director, Mabwell Bioscience
11:15–11:30 Spotlight on Turkey – Doğan Taşkent, Director R&D and Innovation, Atabay Pharmaceuticals
11:3011:45 Spotlight on Brazil – Thiago Rennó dos Mares Guia, Scientific & Business Executive Director, Bionovis
11:45–12:00 Spotlight on Mexico – Ricardo Martín Castro Acosta, Head R&D Biotechnology, Neolpharma
12:00–12:10 Q&A

Coffee Break
Global Growth Strategies

12:30 – 12:45 “Covid 19 effect on Biopharma Industry and Strategic Investments” – Zafer Toksoz, President and Founder, Arven Pharmaceuticals
12:45 -13:00 “Biosimilars in Europe featuring the case-study of biosimilars in ophthalmology” – Andres Gassert, Associate Director Insight & Analytics for Biosimilars and Complex Generics, Teva
13:00 -13:20 Bert Thomas, Senior Vice President, Business Development, Bio-Thera Solutions
13:20-13:35 “Biosimilar: China for Global” – Ping Cao, VP of Business Development, Shanghai Henlius
13:35-13:55 “Spotlight on the US market” – Jeffrey Hausfeld, Chairman of the Board & Chief Medical Officer, BioFactura

13:55 -14:05 Q&A

14:05 -14:30
Start-up Showcase

Get an overview of the selected biotech pipelines, presented by the promising biologics-focused startups from around the globe. Learn about their capabilities and developments.
14:05 – 14:15 Louis Boon, CSO & Board Member, JJP Biologics
14:15 – 14:25 Mauritz Venter, Co-founder & CEO, AzarGen


15:30 - 18:30
Partnering Meetings


February 23 download agenda
Opening Session: Vision for the Future Growth and Success

Moderator: Rahul Garella, Chief Commercial Officer, International Markets, Strides
09:00–09:20 Alejandro Alonso Delgado, Global Director of Portfolio Management & Business Development, Insud Pharma
09:20–09:40 Tackling complex regional development and portfolio in international markets – Deepak Mansukhani, Senior Director and Head of BD, Licensing and Strategic Partnerships, Cipla
09:40–10:00 Creating a roadmap on how to evaluate/value the BD&L opportunities – Nadeem Rehmat, Chief Operating Officer, PharmEvo
10:00–10:20 Strategic approach to the partner selection – Jo Kim, Head and Vice President, Commercial and Supply Chain, Medis
10:20–10:40 Finding the hiding gems in a competitive environment – applicable methods – Shlomo Sadoun, CEO & Co-Founder, SK Pharma Group
10:40–11:00 Q&A

11:00–11:30 Break
Coffee Break
Session: Overview of Geo-opportunities

Moderator: Rafael Ferrer, VP of Corporate Development, moksha8 Pharmaceuticals
11:20–11:40 Spotlight on Russia – Darya Parshina, Director of Business Development, Pharmstandard
11:40–12:00 MENA: opportunities for growth – Madhukar Tanna, Chief Executive Officer, Pharmax Pharmaceuticals (MENA)
12:00–12:40 Spotlight on Ukraine – Oleksandr Torhun, Regulatory Affairs Director, Darnitsa
12:40–13:00 India: Dhagash Vora, Corporate Strategy, Business Development and Licensing, Alkem Laboratories
13:00 – 13:15 Q&A

Partnering Meetings
Evening Function

Sorel’s Bar and Lounge (Marriott, Amsterdam)


February 24 download agenda
Opening Keynote

Introduction to the dynamic Asia Pacific – Mayank Mathuriya, Vice President, Head of Business Development, Menarini Asia Pacific (APAC)

Session One: Exploring the Innovative Potential of APAC Companies
  • What kind of trends are forming in this diversified region and how are regional stakeholders securing successful licensing activity globally?
  • Overview of the crucial partnership factors and licensing considerations for APAC markets: market potential analysis, market entry and partnering strategies, as well as key growing segments overview.

Moderator: Hemant Pachnanda, Head Business Development and Strategy AsiaPacific, Abbott
09:30–09:50 Kanungnij Vuttipakdee, Corporate Head of Business Development, Zuellig Pharma
09:50–10:10 Andy Siow, APAC Commercial Director, Luye Pharma Group
10:10–10:30 Petar Vazharov, Executive Vice President APAC Alvogen, Chief Executive Officer, Lotus Pharmaceuticals
10:30-10:45 Q&A

Session 2: Deep-dive: the SEA outlook presented by the local companies

A country-by-country analysis of licensing opportunities, products needs and business models of interest

Moderator: Mayank Mathuriya, Vice President, Head of Business Development, Menarini Asia Pacific (APAC)
11:20–11:40 Jasmine Karsono, Chief Portfolio & Business Development Officer, KIMIA FARMA (Indonesia)
11:40–12:00 Eelco Broersma, General Manager, Eurodrug (Thailand)
12:00–12:20 Sudeshna Pan,
Business Development Director, Reliv Healthcare (Vietnam)
12:20–12:35 Q&A

12:35 – 13:30


13:30 – 18:00
 1-2-1 Partnering Meetings